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A peptide that cross-reacted with C-terminal gastrin/CCK antisera was isolated from chicken antral extracts 
by a combination of gel filtration and reversed-phase HPLC. The sequence was: Phe-Leu-Pro-His-Val-Phe- 
Ala-Glu-Leu-Ser-Asp-Arg-Lys-Gly-Phe-Val-Gin-Gly-Asn-Giy-Ala-V~-Giu-Ala-Leu-His-Asp-His-Phe- 
Tyr-Pro-As~Trp-jet-Asp-Phe(NH*). Aside from the C-terminal tetrapeptide and the Tyr residue, the mol- 
ecule does not resemble other known forms of gastrin or CCK. The peptide was a potent stimulus of avian 
gastric acid but not pancreatic secretion. The results have important implications for the structure-activity 
and evolutionary relationships of the gastrin/CCK family. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The mammalian peptides gastrin and 
cholecystokinin (CCK) share a C-terminal pen- 
tapeptide sequence that contains the minimal frag- 
ment (Trp-Met-Asp-Phe-NH2) with biological 
activity. It seems possible that these peptides might 
share a common evolutionary history, and it has 
been speculated that they may have arisen by 
divergence following duplication of a common 
ancestral gene [l-3]. Many immunochemical and 
chromatographic, and limited bioassay studies 
have identified gastrin/CCK-like peptides in a 
wide range of submammalian vertebrates, and in- 
vertebrates [2-91. To date, however, no structural 
information has been obtained on such peptides in 
submammalian gut or brain. We report here the 
isolation from chicken antrum, and primary amino 
acid sequence of a novel peptide containing the C- 
terminal tetrapeptide of gastrin/CCK. 
Chicken antrums, collected from a local abat- 
toir, were boiled in water for 10 min (50 g in 
500 ml), homogenised, the pH adjusted to 8.0 with 
ammonia, and centrifuged. The supernatant was 
added to 2 vols isopropanol and stirred overnight 
at 4°C. The aqueous phase was partitioned by ad- 
dition of dichloromethane, aspirated, reduced to 
40 ml by rotary evaporation and applied to a col- 
umn of Sephadex G-50 fine (5 x 100 cm) 
equilibrated with 0.05 M ammonium bicarbonate. 
Some extracts were concentrated on Sep Pak Cle 
cartridges before gel filtration. Radioim- 
munoassay was performed on the G-50 eluates ac- 
cording to published methods using antisera 
(L112, L48) specific for the C-terminus of 
gastrin/CCK [ 10,111. Immunoreactive G-50 
eluates were applied to a Waters radial pak CXS car- 
tridge equiIibrat~ with 0.1 %I trifluoroacetic acid 
(TFA) and eluted with a gradient to 40% 
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acetonitrile. Immunoreactive peaks in the Cis car- 
tridge eluates were purified to homogeneity on a 
Techsil 5 pm Cl8 column and a Vydac 5 pm Cl8 
wide-pore column, equilibrated with 0.1% TFA, 
and eluted with a gradient to 30 or 35% 
acetonitrile. 
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2.2. Trypsinization 
Pure peptide (2-3 nmol) was incubated with 
20 pg TPCK trypsin (Sigma, 12.5 BAAE units//g) 
in 0.05 ammonium bicarbonate at 37°C. After 1 h 
the reaction was halted by the addition of 10~1 
TFA, and the digest microfuged and applied to a 
5 ,um Cl8 Vydac wide pore column equilibrated 
with 0.1% TFA. The sample was eluted with a gra- 
dient to 35% acetonitrile and the column eluate 
assayed with a C-terminal gastrin/CCK antiserum. 
2.3. Amino acid sequence determination 
Approx. 1 nmol pure peptide and its C-terminal 
tryptic fragments were subjected to sequence 
analysis by standard methods using an Applied 
Biosystems gas-phase sequenator. The phenyl- 
thiohydantoin-derivatives amino acids were iden- 
tified by reversed-phase HPLC. 
Fig. 1. Elution profile of gastrin/CCK-like immuno- 
reactivity in chicken antral extracts after reversed-phase 
HPLC. G-50 eluates were adjusted to pH 6.0 and loaded 
onto a Waters p bondapak CM radial compression 
cartridge equilibrated with 0.1% TFA. The column was 
eluted with a gradient to 40% acetonitrile (broken line), 
at a flow rate of 3 ml/min and eluates assayed with C- 
1.4 
2.4. Bioassays 1.2 
Gastric acid secretion in anaesthetised chickens 
and exocrine pancreatic secretion in anaesthetised 
turkeys and rats were determined according to 
[12,13]. The effects of the chicken peptides, 
human heptadecapeptide gastrin (G17) and CCK 
octapeptide (CCK8) were compared in these three 
systems. Doses were established by amino acid 
analysis. 
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3. RESULTS AND DISCUSSION 
Reversed-phase HPLC using the Waters radial 
compression Ci8 cartridge resolved the G-50 
eluates into two well separated peaks of material 
that reacted with antisera specific for the C- 
terminus of gastrin/CCK (fig.1). The later eluting 
peak was purified to homogeneity on Techsil and 
Vydac reversed-phase cl8 columns (fig.2), and 
subjected to sequence analysis. The first 18 
residues were determined, which revealed that 
positions 12 and 13 were Arg-Lys. Further purified 
material was treated with trypsin and the digest 
fractionated by reversed-phase HPLC. Two tryptic 
0.2 
0 
Fig.2. Final purification of the later eluting material 
shown in fig. 1. HPLC-purified material was applied to 
a 5 /cm Vydac Crs wide-pore column (0.46 x 25 cm) 
equilibrated with 0.1% TFA, and eluted with a gradient 
to 35% acetonitrile (broken line) at a flow rate of 
1.25 ml/min. Absorbance was monitored at 214 nm. 
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fragments showed immunoreactivity with C- 
terminal gastrin/CCK antisera (fig.3, peaks A and 
B), and were sequenced. The tryptic peptides dif- 
fered by an amino terminal lysine residue, and one 
was sequenced to completion. Overlapping se- 
quence information on the tryptic fragment and 
the intact molecule enabled assignment of the com- 
plete amino acid sequence of the chicken antral 
peptide (fig.4). C-terminal amidation was inferred 
from the fact that the antisera used to monitor 
purification are virtually unreactive with the 
deamidated forms of gastrin/CCK [ 10,111. 
Moreover, deamidated gastrin is biologically inac- 
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Fig.3. Elution profile of trypsinized chicken antral 
peptide after reversed-phase HPLC. The digest was 
applied to a 5 pm Vydac Cl8 wide pore column. See fig.2 
for elution conditions. Absorbance was monitored at 
214 nm, and column eluates assayed with C-terminal 
gastrin/CCK antiserum L112; only peaks A and B were 
immunoreactive. Arrow indicates the elution position of 
undigested peptide. 
tive (141. The early eluting immunoreactive peak 
from the radial compression Cis eluates was also 
purified further and subjected to sequence 
analysis. However, the apparently homogeneous 
material gave equivocal sequence data; two pep- 
tides were identified and partially co-sequenced 
as Ala-Glu-Leu-Ser-Asp-Arg-Lys-Gly-Phe-( )- 
Gln-Gly . . . and Asp-Arg-Lys-Gly-Phe-Val-Gln . . . 
These sequences correspond to residues 7-18 and 
11-17 of the 36-residue peptide (fig.4). Plainly 
then, the early and late eluting fractions are not 
related in the same way as mammalian G34 and 
G17. For convenience however, we refer to them as 
big and little chicken antral peptides. These data 
provide an explanation for previous results ob- 
tained from gel-filtration studies on antral extracts 
[6-81. The concentration of gastrin/CCK-like im- 
munoreactivity in the antrum (L112) was 6.0 + 
0.8 nmol/g (mean + SE, n = 6), which is about 
lOOO-fold higher than duodenal concentrations. 
Recovery at each purification step was approx. 
70% and 50 g antrums yielded about 15 nmol pure 
36-residue peptide, together with a similar quantity 
of the earlier eluting material (fig.1). These pep- 
tides, then, represent he major antral forms that 
react with C-terminal gastrin/CCK antisera. 
In anaesthetised chickens, infusion of the 
36-residue peptide at a dose of 9 pmol/kg per min 
promptly stimulated acid secretion from a basal 
level of 158.1 + 39amol/lO min to 287.5 + 
37.7 pmol/ 10 min (mean + SE, n = 7). Similar in- 
creases over basal were elicited by the smaller 
chicken peptides at a dose of 5 pmol/kg per min or 
by human G17 at 18 pmol/kg per min. At these 
doses, all peptides also markedly increased the rate 
of pepsin secretion. In contrast, neither chicken 
peptide fraction, nor human G17 significantly 
stimulated pancreatic flow rate or enzyme secre- 
tion in rats or turkeys at doses up to 2 nmol/kg; 
CCK8 markedly stimulated pancreatic flow rate 
and enzyme secretion at a dose of 100 pmol/kg. 
Previous studies have shown that partially purified 
extracts of chicken antrum stimulate acid secretion 
in mammals [8,15]. Moreover, the extracts had a 
gastrin-like rather than CCK-like action in 
radioreceptor assays that clearly distinguish the 
two types of bioactivity [8]. 
However, there are several striking structural 
features that distinguish the chicken antral peptide 
from known mammalian gastrins. First, the 
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Fig.4. Amino acid sequence of chicken antral peptide.+, residues determined from sequencing of intact peptide. -, 
residues determined from sequencing of tryptic peptide A. C, residues determined from sequencing of tryptic peptide 
B. Trp at position 33 was equivocal, but confirmed by absorbance at 280 nm. The C-terminal amide was assigned on 
the basis of biological activity, and cross-reactivity with C-terminal gastrin/CCK antisera (see text). 
Chicken gastrin 
Porcine CCK33 
Porcine G34 l QLG LQGPPH 
Fig.5. Amino acid sequences of chicken antral peptide (labelled chicken gastrin), porcine big gastrin (G34) and porcine 
CCK33, aligned at the C-terminus. *Q, pyrrolidone carboxylic acid; C-terminal phenylalanine r sidues are all amidated. 
Common residues are boxed. 
tyrosine residue occurs in the seventh position 
counting from the C-terminus which is 
characteristic of CCK, rather than gastrin where 
Tyr is the sixth residue from the C-terminus. 
Second, the amino terminus is not blocked, in con- 
trast with the major mammalian forms of gastrin, 
G17 and G34. Third, the polyglutamic acid se- 
quence of mammalian G17 is absent. When the 
biologically active C-terminal regions are aligned, 
the chicken peptide shares only 4 residues with por- 
cine G34, and 7 with porcine CCK33 (fig.5). In 
mammals gastrins occur in sulphated and un- 
sulphated forms, whereas CCK is always 
sulphated. It remains to be determined if the 
tyrosine residue in the chicken peptide may be 
substituted in this way; such a modification would 
not be expected to alter the potency for gastric acid 
secretion [ 161. 
Thus, although the chicken antral peptide 
resembles CCK more than gastrin in its structure, 
it originates from a region that is considered to be 
the counterpart of the mammalian pyloric antrum 
[7], and has the biological properties of gastrin. 
The idea deserves consideration therefore that this 
peptide represents ‘avian gastrin’. 
There is evidence that birds have separate CCK- 
like molecules in brain and intestine [6,8] so the 
present finding has important implications for the 
evolutionary and structure-activity relationships of 
the gastrin/CCK family. 
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